Showing results (311-320 of 532) with videos related to
Sort By:
Pageof 54
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepimeR N Jones, D J Biedenbach, S A Marshall, et al.Antimicrobial Agents and Chemotherapy|June 13, 1998
Evaluation of endpoints for antifungal susceptibility determinations with LY303366M E Klepser, E J Ernst, M E Ernst, et al.Diagnostic Microbiology and Infectious Disease|May 23, 1998
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE ProgramM A Pfaller, R N Jones, S A Messer, et al.Infection Control and Hospital Epidemiology|January 1, 1993
Restriction endonuclease analysis of plasmid DNA from methicillin-resistant Staphylococcus aureus: clinical application over a three-year periodA Trilla, M D Nettleman, R J Hollis, et al.Journal of Clinical Microbiology|April 1, 1996
Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazoleJ H Rex, M A Pfaller, M Lancaster, et al.Journal of Clinical Microbiology|May 8, 2003
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazoleM A Pfaller, D J Diekema, L Boyken, et al.Journal of Clinical Microbiology|May 8, 2003
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic locationM A Pfaller, S A Messer, L Boyken, et al.Antimicrobial Agents and Chemotherapy|October 18, 2002
In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methodsM A Pfaller, S A Messer, L Boyken, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2000
Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibilityH Wisplinghoff, M B Edmond, M A Pfaller, et al.Journal of Clinical Microbiology|November 6, 2004
Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida speciesM A Pfaller, L Boyken, S A Messer, et al.Pageof 54